CD26 overexpression is observed in ovarian cancer [14], thyroid cancer [15], malignant mesothelioma [16], colorectal cancer [17], prostate cancer [18], and osteosarcoma [19]. This evidence concerns the gene DPP4 and colorectal cancer.